Recombinant Swinepox virus expressing β-galactosidase: Investigation of vital host range and gene expression levels in cell culture

Virology

Volumn 243, Issue 2, 1998, Pages 396-405

  Bárcena, Juan ^a   Blasco, Rafael ^a,b  

^a Ctro Invest Sanid Anim V   (Spain)

^b Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria   (Spain)

Author keywords

E. coli galactosidase; Eukaryotic expression vector; Poxviridae; Swinepox virus

Indexed keywords

BETA GALACTOSIDASE;

ANIMAL CELL; ARTICLE; EMBRYO; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE EXPRESSION; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SWINE DISEASE; VIRUS INFECTION; VIRUS RECOMBINANT;

ANIMALIA; DNA VIRUSES; ESCHERICHIA COLI; EUKARYOTA; POXVIRIDAE; SUIDAE; SUS SCROFA; SWINEPOX VIRUS; SWINEPOX VIRUS (STRAIN KASZA); VACCINIA; VACCINIA VIRUS;

EID: 0032502737     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9053     Document Type: Article

References (47)

1. Beattie E., Kauffman E. B., Martinez H., Perkus M. E., Jacobs B. L., Paoletti E., Tartaglia J. Host-range restriction of vaccinia virus E3L-specific deletion mutants. Virus Genes. 12:1996;89-94.
2. Blasco R., Moss B. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-dalton outer envelope protein. J. Virol. 65:1991;5910-5920.
3. Blasco R., Moss B. Role of cell-associated enveloped vaccinia virus in cell-to-cell virus spread. J. Virol. 66:1992;4170-4179.
4. Blasco R., Moss B. Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene. 158:1995;157-162.
5. Boyle D. B. Quantitative assessment of poxvirus promoters in fowlpox and vaccinia virus recombinants. Virus Genes. 6:1992;281-290.
6. Boyle D. B., Coupar B. E. Identification and cloning of the fowlpox virus thymidine kinase gene using vaccinia virus. J. Gen. Virol. 67:1986;1591-1600.
7. Brooks M. A., Ali A. N., Turner P. C., Moyer R. W. A rabbitpox virus serpin gene controls host range by inhibiting apoptosis in restrictive cells. J. Virol. 69:1995;7688-7698.
8. Buller R. M., Smith G. L., Cremer K., Notkins A. L., Moss B. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature. 317:1985;813-815.
9. Chakrabarti S., Brechling K., Moss B. Vaccinia virus expression vector: Coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell Biol. 5:1985;3403-3409.
10. Chang H. W., Uribe L. H., Jacobs B. L. Rescue of vaccinia virus lacking the E3L gene by mutants of E3L. J. Virol. 69:1995;6605-6608.
11. Chen W., Drillien R., Spehner D., Buller R. M. Restricted replication of ectromelia virus in cell culture correlates with mutations in virus-encoded host range gene. Virology. 187:1992;433-442.
12. Datt N. S. Comparative studies of pigpox and vaccinia viruses. J. Comp. Pathol. 74:1964;62-69.
13. Davison A. J., Moss B. Structure of vaccinia virus early promoters. J. Mol. Biol. 210:1989a;749-769.
14. Davison A. J., Moss B. Structure of vaccinia virus late promoters. J. Mol. Biol. 210:1989b;771-784.
15. De Boer G. F. Swinepox. Virus isolation, experimental infections and the differentiation from vaccinia virus infections. Arch. Virol. 49:1975;141-150.
16. Drillien R., Koehren F., Kirn A. Virology. 111:1981;488-499.
17. Drillien R., Spehner D., Kirn A. Host range restriction of vaccinia virus in Chinese hamster ovary cells: Relationship to shutoff of protein synthesis. J. Virol. 28:1978;843-850.
18. Earl P., Moss B. Expression of proteins in mammalian cells using vaccinia viral vectors. Current Protocols in Molecular Biology. 1991;Wiley-Interscience, New York.
19. Fenner F., Wittek R., Dumbell K. R. The Orthopoxviruses. 1989;Academic Press, San Diego.
20. Foley P. L., Paul P. S., Levings R. L., Hanson S. K., Middle L. A. Swinepox virus as a vector for the delivery of immunogens. Ann. N.Y. Acad. Sci. 646:1991;220-222.
21. Garg S. K., Meyer R. C. Adaptation of swinepox virus to an established cell line. Appl. Microbiol. 23:1972;180-218.
22. Gillard S., Spehner D., Drillien R. Mapping of a vaccinia host range sequence by insertion into the viral thymidine kinase gene. J. Virol. 53:1985;316-318.
23. Hruby D. E., Lynn D. L., Condit R. C., Kates J. R. Cellular differences in the molecular mechanisms of vaccinia virus host range restriction. J. Gen. Virol. 47:1980;485-488.
24. Kasza L., Bohl E. H., Jones D. O. Isolation and cultivation of swine pox virus in primary cell cultures of swine origin. Am. J. Vet. Res. 21:1960;269-273.
25. Kasza L., Griesemer R. A. Experimental swine pox. Am. J. Vet. Res. 23:1962;443-451.
26. Kumar S., Boyle D. B. Activity of a fowlpox virus late gene promoter in vaccinia and fowlpox virus recombinants. Arch. Virol. 112:1990;139-148.
27. Liu G. Q., Cao X., Zhu J. M., Ren G. F., Li H. M., Xie Y. X., Peng W. Selection of recombinant vaccinia viruses (Tian Tan strain) expressing hepatitis B virus surface antigen by using beta-galactosidase as a marker. Sci. China [B]. 33:1990;188-197.
28. Mahnel H. Swinepox. Pensaert M. B. Virus Infections of Porcines. 1989;3-14 Elsevier, Amsterdam.
29. Massung R. F., Jayarama V., Moyer R. W. DNA sequence analysis of conserved and unique regions of swinepox virus: Identification of genetic elements supporting phenotypic observations including a novel G protein-coupled receptor homologue. Virology. 197:1993;511-528.
30. Massung R. F., Moyer R. W. The molecular biology of swinepox virus. II. The infectious cycle. Virology. 180:1991;355-364.
31. Mayr A. Experimentelle untersuchungen über das virus der originären schweinepocken. Arch. Gesamte Virusforsch. 9:1959;156-192.
32. Meyer R. C., Conroy J. D. Experimental swinepox in gnotobiotic piglets. Res. Vet. Sci. 13:1972;334-338.
33. Moss B. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc. Natl. Acad. Sci. USA. 93:1996;11341-11348.
34. Ouchi M., Fujiwara M., Hatano Y., Yamada M., Nii S. Analysis of swinepox virus antigens using monoclonal antibodies. J. Vet. Med. Sci. 54:1992;731-737.
35. Panicali D., Grzelecki A., Huang C. Vaccinia virus vectors utilizing the beta-galactosidase assay for rapid selection of recombinant viruses and measurement of gene expression. Gene. 47:1986;193-199.
36. Paoletti E. Applications of pox virus vectors to vaccination: an update. Proc. Natl. Acad. Sci. USA. 93:1996;11349-11353.
37. Paton D. J., Brown I. H., Fitton J., Wrathall A. E. Congenital pig pox: A case report. Vet. Rec. 127:1990;204-204.
38. Pearson A., Richardson C., Yuen L. The 5′ noncoding region sequence of the Choristoneura biennis entomopoxvirus spheroidin gene functions as an efficient late promoter in the mammalian vaccinia expression system. Virology. 180:1991;561-566.
39. Perkus M. E., Goebel S. J., Davis S. W., Johnson G. P., Limbach K., Norton E. K., Paoletti E. Vaccinia virus host range genes. Virology. 179:1990;276-286.
40. Prideaux C. T., Kumar S., Boyle D. B. Comparative analysis of vaccinia virus promoter activity in fowlpox and vaccinia virus recombinants. Virus Res. 16:1990;43-57.
41. Schwarte L. H., Biester H. E. Pox in swine. Am. J. Vet. Res. 2:1941;136-140.
42. Somogyi P., Frazier J., Skinner M. A. Fowlpox virus host range restriction: Gene expression, DNA replication, and morphogenesis in nonpermissive mammalian cells. Virology. 197:1993;439-444.
43. Spehner D., Drillien R., Lecocq J. P. Construction of fowlpox virus vectors with intergenic insertions: Expression of the beta-galactosidase gene and the measles virus fusion gene. J. Virol. 64:1990;527-533.
44. Sutter G., Moss B. Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc. Natl. Acad. Sci. USA. 89:1992;10847-10851.
45. Tartaglia J., Cox W. I., Taylor J., Perkus M., Riviere M., Meignier B., Paoletti E. Highly attenuated poxvirus vectors. AIDS Res. Hum. Retroviruses. 8:1992;1445-1447.
46. Tuboly T., Nagy E., Derbyshire J. B. Potential viral vectors for the stimulation of mucosal antibody responses against enteric viral antigens in pigs. Res. Vet. Sci. 54:1993;345-350.
47. van der Leek M. L., Feller J. A., Sorensen G., Isaacson W., Adams C. L., Borde D. J., Pfeiffer N., Tran T., Moyer R. W., Gibbs E. P. Evaluation of swinepox virus as a vaccine vector in pigs using an Aujeszky's disease (pseudorabies) virus gene insert coding for glycoproteins gp50 and gp63. Vet. Rec. 134:1994;13-18.